United Kingdom· GB-APID-4824911000001106
Glypressin 1mg powder and solvent for solution for injection vials
A terlipressin product containing terlipressin, registered in United Kingdom by Ferring Pharmaceuticals Ltd. The same ATC class is registered in 15 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Terlipressin is registered in 15 of 19 countries.
Countries holding a registration under ATC H01BA04 (terlipressin), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 9 of them publish a price we can compare per daily dose
Terlipressin · ATC H01BA04
15 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Terlipressin
- Manufacturer
- Ferring Pharmaceuticals Ltd
- Country
- United Kingdom (GB)
- ATC code
- H01BA04
- ATC class
- Terlipressin
- Defined daily dose
- 12 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05015919401812
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Terlipressin in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainGLYPRESSIN 1mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEFerring S.A.U.
- IcelandGlypressinFerring Lægemidler A/S
- FranceACETATE DE TERLIPRESSINE EVER PHARMA 0,2 mg/ml, solution injectableEVER VALINJECT (AUTRICHE)
- PolandGlypressinFerring GmbH
- SwitzerlandCurapressin 1 mg/5 ml, InjektionslösungCuratis AG
- NetherlandsGlypressin 0,1 mg/ml, oplossing voor injectieFerring B.V.
- GermanyGlycylpressinFerring Gmbh
- United StatesTerlivazMallinckrodt Hospital Products Inc.
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Glycylpressin, Terlipressinacetat Ever Pharma
- Bulgaria · Терлипресин Ацетат Ever Pharma
- Czechia · Remestyp, Terlipresin Acetát Ever Pharma
- Germany · Glycylpressin, Terlipressinacetat Ever Pharma
- Spain · Terlipresina Acetato Ever Pharma
- France · Acetate De Terlipressine Ever Pharma
- Hungary · Glypressin
- Ireland · Terlipressin Acetate Ever Pharma
- Italy · Glipressina, Terlipressina Acetato Ever Pharma
- Poland · Terlipressini Acetas Ever Pharma
- Portugal · Glypressine, Terlipressina Ever Pharma
- Romania · Acetat De Terlipresină Ever Pharma
- Slovakia · Remestyp, Terlipresín Ever Pharma
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2f957e12-0698-45e7-b3dc-4cea8fc551f6 GET /v1/drugs/2f957e12-0698-45e7-b3dc-4cea8fc551f6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4824911000001106",
"desc": "Glypressin 1mg powder and solvent for solution for injection vials (Ferring Pharmaceuticals Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "38750511000001105",
"source": "dmd",
"vtm_id": "777717004",
"strength": "1 mg",
"substance": "Terlipressin",
"ingredient": "Terlipressin acetate",
"supplier_code": "129801000001101"
}See everything about terlipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.